肿瘤浸润自然杀伤细胞。
Tumor-Infiltrating Natural Killer Cells.
机构信息
Innate Pharma Research Laboratories, Innate Pharma, Marseille, France.
Center of Excellence for Biomedical Research, University of Genoa, Genoa, Italy.
出版信息
Cancer Discov. 2021 Jan;11(1):34-44. doi: 10.1158/2159-8290.CD-20-0655. Epub 2020 Dec 4.
Abstract
Because of their potent antitumor activity and their proinflammatory role, natural killer (NK) cells are at the forefront of efforts to develop immuno-oncologic treatments. NK cells participate in immune responses to tumors by killing target cells and producing cytokines. However, in the immunosuppressive tumor microenvironment, NK cells become dysfunctional through exposure to inhibitory molecules produced by cancer cells, leading to tumor escape. We provide an overview of what is known about NK tumor infiltration and surveillance and about the mechanisms by which NK cells become dysfunctional. SIGNIFICANCE: The functions of tumor-infiltrating NK cells may be impaired. This review aims to describe the various mechanisms by which tumors alter NK-cell functions.
摘要
由于其强大的抗肿瘤活性和促炎作用，自然杀伤 (NK) 细胞成为免疫肿瘤治疗发展的前沿。NK 细胞通过杀死靶细胞和产生细胞因子参与肿瘤的免疫反应。然而，在免疫抑制的肿瘤微环境中，NK 细胞通过暴露于癌细胞产生的抑制分子而功能失调，导致肿瘤逃逸。我们概述了 NK 细胞浸润和监测肿瘤以及 NK 细胞功能失调的机制。意义：肿瘤浸润 NK 细胞的功能可能受损。本综述旨在描述肿瘤改变 NK 细胞功能的各种机制。
相似文献
1
Tumor-Infiltrating Natural Killer Cells.
Cancer Discov. 2021 Jan;11(1):34-44. doi: 10.1158/2159-8290.CD-20-0655. Epub 2020 Dec 4.
2
Functional and metabolic targeting of natural killer cells to solid tumors.
Cell Oncol (Dordr). 2020 Aug;43(4):577-600. doi: 10.1007/s13402-020-00523-7. Epub 2020 Jun 2.
3
Leveraging NKG2D Ligands in Immuno-Oncology.
Front Immunol. 2021 Jul 29;12:713158. doi: 10.3389/fimmu.2021.713158. eCollection 2021.
4
Influence of the Tumor Microenvironment on NK Cell Function in Solid Tumors.
Front Immunol. 2020 Jan 21;10:3038. doi: 10.3389/fimmu.2019.03038. eCollection 2019.
5
Natural killer group 2D receptor and its ligands in cancer immune escape.
Mol Cancer. 2019 Feb 27;18(1):29. doi: 10.1186/s12943-019-0956-8.
6
Natural Killer Cell Interactions With Myeloid Derived Suppressor Cells in the Tumor Microenvironment and Implications for Cancer Immunotherapy.
Front Immunol. 2021 May 5;12:633205. doi: 10.3389/fimmu.2021.633205. eCollection 2021.
7
Escape of tumor cells from the NK cell cytotoxic activity.
J Leukoc Biol. 2020 Oct;108(4):1339-1360. doi: 10.1002/JLB.2MR0820-652R. Epub 2020 Sep 15.
8
NK cell receptors in anti-tumor and healthy tissue protection: Mechanisms and therapeutic advances.
Immunol Lett. 2024 Dec;270:106932. doi: 10.1016/j.imlet.2024.106932. Epub 2024 Sep 18.
9
Cytokines Orchestrating the Natural Killer-Myeloid Cell Crosstalk in the Tumor Microenvironment: Implications for Natural Killer Cell-Based Cancer Immunotherapy.
Front Immunol. 2021 Jan 29;11:621225. doi: 10.3389/fimmu.2020.621225. eCollection 2020.
10
Inherent and Tumor-Driven Immune Tolerance in the Prostate Microenvironment Impairs Natural Killer Cell Antitumor Activity.
Cancer Res. 2016 Apr 15;76(8):2153-65. doi: 10.1158/0008-5472.CAN-15-1965. Epub 2016 Apr 5.
引用本文的文献
1
PD-1 NK cell subsets in high grade serous ovarian cancer: an indicator of disease severity and a target for combined immune-checkpoint blockade.
J Exp Clin Cancer Res. 2025 Aug 29;44(1):258. doi: 10.1186/s13046-025-03508-2.
2
Tumor Microenvironmental Dynamics in Shaping Resistance to Therapeutic Interventions in Melanoma: A Narrative Review.
Pharmaceuticals (Basel). 2025 Jul 22;18(8):1082. doi: 10.3390/ph18081082.
3
CAR Cell-Derived Exosomes in Cancer Therapy: Biogenesis, Engineering Strategies and Antitumor Mechanisms.
Int J Mol Sci. 2025 Aug 15;26(16):7890. doi: 10.3390/ijms26167890.
4
Recent advances in tumor immunotherapy based on NK cells.
Front Immunol. 2025 Aug 7;16:1595533. doi: 10.3389/fimmu.2025.1595533. eCollection 2025.
5
Unleashing NK cells for cancer immunotherapy in lung cancer: biologic challenges and clinical advances.
J Exp Clin Cancer Res. 2025 Aug 23;44(1):251. doi: 10.1186/s13046-025-03503-7.
6
VHL restoration in clear cell renal cell carcinoma improves NK cell infiltration and function.
Cancer Immunol Immunother. 2025 Jul 30;74(9):278. doi: 10.1007/s00262-025-04132-x.
7
Effects of Bojungikki-Tang on immune response and clinical outcomes in NSCLC patients receiving immune checkpoint inhibitors: a randomized pilot study.
BMC Cancer. 2025 Jul 29;25(1):1229. doi: 10.1186/s12885-025-14629-4.
8
Subtype- and race-specific variations in the immune landscape of breast cancer: therapeutic implications.
NPJ Breast Cancer. 2025 Jul 24;11(1):78. doi: 10.1038/s41523-025-00799-8.
9
Characteristic expression profile of small nucleolar RNAs and their association with tumor immune microenvironment in papillary thyroid carcinoma.
BMC Cancer. 2025 Jul 1;25(1):1073. doi: 10.1186/s12885-025-14498-x.
10
CAR Beyond αβ T Cells: Unleashing NK Cells, Macrophages, and γδ T Lymphocytes Against Solid Tumors.
Vaccines (Basel). 2025 Jun 19;13(6):654. doi: 10.3390/vaccines13060654.
本文引用的文献
1
Overexpression of an Immune Checkpoint (CD155) in Breast Cancer Associated with Prognostic Significance and Exhausted Tumor-Infiltrating Lymphocytes: A Cohort Study.
J Immunol Res. 2020 Jan 13;2020:3948928. doi: 10.1155/2020/3948928. eCollection 2020.
2
Comprehensive Phenotyping of Human PB NK Cells by Flow Cytometry.
Cytometry A. 2020 Sep;97(9):891-899. doi: 10.1002/cyto.a.24001. Epub 2020 Mar 21.
3
A comprehensive approach to gene expression profiling in immune cells.
Methods Enzymol. 2020;636:1-47. doi: 10.1016/bs.mie.2019.07.005. Epub 2019 Aug 7.
4
Minimal PD-1 expression in mouse and human NK cells under diverse conditions.
J Clin Invest. 2020 Jun 1;130(6):3051-3068. doi: 10.1172/JCI133353.
5
Discovery of specialized NK cell populations infiltrating human melanoma metastases.
JCI Insight. 2019 Dec 5;4(23):133103. doi: 10.1172/jci.insight.133103.
6
Expression profiling of single cells and patient cohorts identifies multiple immunosuppressive pathways and an altered NK cell phenotype in glioblastoma.
Clin Exp Immunol. 2020 Apr;200(1):33-44. doi: 10.1111/cei.13403. Epub 2019 Dec 16.
7
Activating killer cell immunoglobulin-like receptors: Detection, function and therapeutic use.
Int J Immunogenet. 2020 Feb;47(1):1-12. doi: 10.1111/iji.12461. Epub 2019 Nov 22.
8
Mitochondrial fragmentation limits NK cell-based tumor immunosurveillance.
Nat Immunol. 2019 Dec;20(12):1656-1667. doi: 10.1038/s41590-019-0511-1. Epub 2019 Oct 21.
9
NK Cell Metabolism and Tumor Microenvironment.
Front Immunol. 2019 Sep 24;10:2278. doi: 10.3389/fimmu.2019.02278. eCollection 2019.
10
IL-6 and IL-8 secreted by tumour cells impair the function of NK cells via the STAT3 pathway in oesophageal squamous cell carcinoma.
J Exp Clin Cancer Res. 2019 Jul 19;38(1):321. doi: 10.1186/s13046-019-1310-0.
Zotero 插件